Imatinib therapy of chronic myeloid leukemia restores the expression levels of key genes for DNA damage and cell-cycle progression-Reference-Cited by-同舟云学术

Imatinib therapy of chronic myeloid leukemia restores the expression levels of key genes for DNA damage and cell-cycle progression

Published:2012-05 Issue:5 Volume:22 Page:381-388
ISSN:1744-6872
Container-title:Pharmacogenetics and Genomics
language:en
Short-container-title:

Author:

Benito Rocío,Lumbreras Eva,Abáigar María,Gutiérrez Norma C.,Delgado Manuel,Robledo Cristina,García Juan L.,Rodríguez-Vicente Ana E.,Cañizo M. Consuelo,Rivas Jesús Maria Hernández

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Genetics (clinical),Genetics,Molecular Biology,Molecular Medicine,General Pharmacology, Toxicology and Pharmaceutics

Reference46 articles.

1. FoxO tumor suppressors and BCR-ABL-induced leukemia: a matter of evasion of apoptosis.;Jagani;Biochim Biophys Acta,2008

2. Induction of chronic myelogenous leukemia in mice by the P210bcrabl gene of the Philadelphia chromosome.;Daley;Science,1990

3. The biology of CML blast crisis.;Calabretta;Blood,2004

4. Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene.;Sawyers;J Exp Med,1995

5. Transformation of hematopoietic cells by BCRABL requires activation of a PI-3kAkt-dependent pathway.;Skorski;EMBO J,1997

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradation;Biomarker Research;2024-05-04

2. The mRNA Expression of PTEN, LEF1, JAK3, LC3 and p62/SQSTM1 Genes in Patients with Chronic Myeloid Leukemia;Cardiovascular & Hematological Agents in Medicinal Chemistry;2023-03

3. Combined PARP inhibitors and small molecular inhibitors in solid tumor treatment (Review);International Journal of Oncology;2023-01-04

4. RanBP3 Regulates Proliferation, Apoptosis and Chemosensitivity of Chronic Myeloid Leukemia Cells via Mediating SMAD2/3 and ERK1/2 Nuclear Transport;Frontiers in Oncology;2021-08-24

5. Overexpressed long noncoding RNA CRNDE with distinct alternatively spliced isoforms in multiple cancers;Frontiers of Medicine;2019-06